FIELD: medicine.
SUBSTANCE: in males with mucinous gastric carcinoma after a curative resection to the extent of gastrectomy, tumor tissue is analysed for the level of testosterone. If the tissue value is 7.8±0.6 ng/g, process generalisation within 6 to 12 months is predicted; the level of tissue testosterone 174.5±15.6 ng/g enables predicting the favourable clinical course of the process, prolongation of the patient's life.
EFFECT: method allows the objective assessment of the pathological process directionality, the well-timed prediction of developing generalisation and taking adequate therapeutic measures.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF LIVER METASTASES IN RECTAL CANCER | 2014 |
|
RU2585122C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
| METHOD FOR SPECIFYING DIRECTIONALITY OF PATHOLOGICAL PROCESS IN LUNG CANCER | 2009 |
|
RU2440037C2 |
| METHOD FOR PREDICTION OF DISEASE OUTCOME IN PATIENTS WITH GASTRIC CANCER AFTER SURGICAL MANAGEMENT | 2018 |
|
RU2696054C1 |
| METHOD FOR PREDICTION OF PERITONEAL METASTASES OF GASTRIC CANCER | 2018 |
|
RU2686689C1 |
| METHOD OF PREDICTING DEVELOPMENT OF CEREBRAL METASTASES IN CASE OF LUNG CANCER IN WOMEN | 2009 |
|
RU2439579C2 |
| METHOD OF TREATING SIGNET RING CELL STOMACH CARCINOMA | 2010 |
|
RU2428993C1 |
| METHOD OF TREATING SIGNET-RING CELL CARCINOMA OF STOMACH | 2009 |
|
RU2414890C1 |
| METHOD FOR PREDICTION OF DURATION OF RECURRENCE-FREE INTERVAL IN PATIENTS WITH RECTAL CANCER | 2009 |
|
RU2415429C1 |
| TEST SYSTEM “HV2 mtDNA-PCR” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH GASTRIC CANCER | 2017 |
|
RU2683571C1 |
